Navigation Links
New therapy with stem cells to treat Crohn's disease
Date:2/19/2009

  • When drugs don't work and surgery is not possible, transplanting stem cells from the patient's own bone marrow is an effective alternative for the treatment of this chronic disease.

  • The procedure has been tested successfully in the US and Italy, where total remission of the disease has been shown in 80% of cases, and considerable improvement in quality of life in the remaining 20% of cases. Since August 2008, Hospital Clnic has used this therapy in a total of 6 patients.

  • In Spain, this disease affects 1% of the population between 18 and 40 years of age and each year approximately 2000 new cases are diagnosed. This regenerative therapy constitutes a new focus on the use of stem cells in intestinal diseases.

Barcelona, February 19, 2009. Cellular therapy with stem cells is revolutionizing the focus of treatment of many serious diseases. Replacing the cells of damaged tissue with other new cells from the same patient is already a reality. This is the basis of cellular therapy and regenerative medicine, the latest great advance in biomedicine. In this line, Hospital Clnic, Barcelona is leading the world in the application of an innovative cellular therapy that uses stem cells to treat Crohn's disease, a chronic genetic disease that affects 1% of the population in Spain and which has considerable impact on the quality of life of the patients. The procedure is based on an autologous bone-marrow transplant (when patients receive a transplant of their own stem cells) and now constitutes a treatment option to cure an intestinal disease that sometimes does not successfully respond to drugs and requires highly complex surgery that does not provide a cure.

Hospital Clnic, Barcelona is one of the few hospitals in the world to apply this new therapeutic option for patients with Crohn's disease, and it does so with the guarantee of success experienced in the US and Italy, where the technique has been tested with excell
'/>"/>

Contact: Maria Trenzado
trenzado@clinic.ub.es
34-932-275-700
IDIBAPS - Institut d'Investigacions Biomdiques August Pi i Sunyer
Source:Eurekalert  

Page: 1 2 3 4 5

Related medicine news :

1. A potential molecular target for biotherapy esophageal squamous cell carcinomas
2. What is the most effective therapy for low-dose aspirin induced peptic ulcer?
3. Varian Medical Systems Has Received CE Mark for Proton Therapy System
4. Dr. Larry Kaskel, Medical Director of the Heart Attack Prevention Center, to Speak March 4th at CardioCareLive about FirstLine Therapy
5. Apple's iPod Touch Joins the iPhone as a Stuttering Therapy Tool At Hollins Communications Research Institute
6. Supplement of probiotics provides a new therapy for ulcerative colitis
7. An adjuvant chemotherapeutic agent in gastric cancer therapy
8. MU researcher demonstrates non-traditional therapy is effective as pain management
9. Public Cancer Center Becomes First in South-East Asia to Introduce RapidArc Radiotherapy Treatments From Varian Medical Systems
10. Lung Cancer Microscopic Appearance Affects Response to Chemotherapy
11. Gene Therapy Holds Promise for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New therapy with stem cells to treat Crohn's disease
New therapy with stem cells to treat Crohn's disease
Breaking Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3The American Society of Transplantation Announces Dr Joren C Madsen as President 49219 1The American Society of Transplantation Announces Dr Joren C Madsen as President 49219 2BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 1BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 2BenefitMall Hosts New World of Healthcare Forum to Empower Partners to Find Solutions for Volatile Healthcare Industry 49218 3John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 1John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 2John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 3John Hancock Announces Enhancements to Group Long Term Care 28LTC 29 Insurance Products and Discount Program 49216 4